CCDC166

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, CCDC166 mutation is significantly associated with the RNA expression of many other genes, with 64 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CCDC166-associated genes across cancer lineages are RNA5SP261, USP17L3, and ATP6V1G3. Each is linked with CCDC166 in more than 1 cancer types. Because this analysis shows association rather than direction, both CCDC166-to-partner and partner-to-CCDC166 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP261 grouped by CCDC166-low versus CCDC166-high in BRCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CCDC166→partner) and Y-score (partner→CCDC166) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCARNA5SP261 →+0.291+8.055<.001.00731
BRCAUSP17L3 →+0.024+8.055<.001.00731
UCECATP6V1G3 →+0.999+2.695<.001.00431
UCECALX3 →+0.601+3.968.005<.00131
UCECSSTR5 →+0.564+2.871.009.00831
UCECZIC5 →+1.648+3.600<.001.00431
Each partner links to its Q-omics profile. Showing the 6 strongest of 64 associations by consensus.

RNA5SP261 by CCDC166 expression — BRCA

Box plot of RNA5SP261 in CCDC166-low vs CCDC166-high samples in BRCA.

Explore this box plot interactively →

Exploration